BUSINESS● LOW3h ago · Sep 3, 2026, 5:10 PM
Moderna slips as Rothschild issues rare Sell rating after cancer vaccine-led rally
Seeking Alpha Tech · global
Moderna's stock declined after Rothschild issued a rare 'Sell' rating following a rally driven by cancer vaccine news. This indicates a notable shift in analyst sentiment for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS9m agoMDxHealth SA GAAP EPS of -$0.37, revenue of $51.11MSeeking Alpha TechBUSINESS11m agoSA analyst: Inflation relief could fuel broader stock market rallySeeking Alpha TechBUSINESS11m agoPro-Dex GAAP EPS of $0.87 beats by $0.20, revenue of $20.4M beats by $1.2MSeeking Alpha TechBUSINESS13m agoNetwork-1 Technologies declares $0.05 dividendSeeking Alpha Tech